🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

26 recruiting trials

for Resectable Pancreatic Ductal Adenocarcinoma

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer NCT04969731Phase 31 site📍 Seoul GC Cell Corporation · Tests: Immuncell-LC, Gemcitabine DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer NCT07705919Phase 1, Phase 21 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Computed Tomography, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Fluorouracil, Gadoli… Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment NCT06574620NA1 site📍 Vancouver British Columbia Cancer Agency · Tests: Genetic testing, Optional biopsy, Tissue collection Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma NCT05688215Phase 1, Phase 21 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Biospecimen Collection, Computed Tomography, Core Biopsy, Fluorouracil, Irinotecan Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer NCT06782932Phase 1, Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: AGEN2373, Balstilimab, Cyclophosphamide, GVAX, AGEN2373 (RP2D) Durvalumab and Oleclumab in Resectable PDAC NCT06060405Phase 21 site📍 Toronto University Health Network, Toronto · Tests: Durvalumab, Oleclumab Pancreatic Cancer Detection Consortium NCT06388967n/a13 sites📍 Phoenix📍 Scottsdale📍 Monrovia City of Hope Medical Center · Tests: PANcreatic cancer Exosome Early detectiON (PANXEON) Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer NCT07645651Phase 11 site📍 Seattle University of Washington · Tests: Samuraciclib, Computed Tomography, Endoscopic Ultrasound Biopsy, Biospecimen Collection Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer NCT06423326Phase 22 sites📍 Washington D.C.📍 Atlanta Georgetown University · Tests: Biopsy, Biospecimen Collection, Cisplatin, Computed Tomography, Gemcitabine Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) NCT07252232Phase 386 sites📍 Birmingham📍 Phoenix📍 Scottsdale Revolution Medicines, Inc. · Tests: daraxonrasib PULSAR in Systemic Therapy for Pancreatic Cancer NCT07269626Phase 21 site📍 Seoul Samsung Medical Center · Tests: Personalized Ultrafractionated Adaptive Radiotherapy Targeted Pathway Inhibition in Patients With Pancreatic Cancer NCT04005690EARLY Phase 11 site📍 Portland OHSU Knight Cancer Institute · Tests: Cobimetinib, Olaparib, Onvansertib, Azenosertib, Saruparib Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer NCT05132504Phase 23 sites📍 Houston📍 Houston📍 Houston Baylor College of Medicine · Tests: Pembrolizumab, Folfirinox Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer NCT06639724Phase 11 site📍 La Jolla University of California, San Diego · Tests: Fostamatinib in combination with chemotherapy (gemcitabine and nab-paclitaxel) Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer NCT03977233Phase 21 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Oxaliplatin, Leucovorin, Irinotecan Hydrochloride, 5-FU Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy NCT06595160n/a1 site📍 Atlanta Emory University · Tests: Non-Interventional Study AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma NCT06320717n/a2 sites📍 Buffalo📍 West Islip Roswell Park Cancer Institute · Tests: Blood sample AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer NCT07619313Phase 11 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Biopsy Procedure, Cisplatin, Computed Tomography, Durvalumab, Fluorouracil A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer NCT07671339Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: ELI-002 7P, Tislelizumab, mFOLFIRINOX A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer NCT07024615Phase 13 sites📍 Boston📍 New York📍 Durham Astellas Pharma Global Development, Inc. · Tests: ASP2138, Oxaliplatin, Leucovorin, 5-FU, Irinotecan French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC) NCT06287749n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Blood sample/Liquid Biopsy PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) NCT06673017Phase 19 sites📍 Newport Beach📍 Miami📍 Detroit PanTher Therapeutics · Tests: PTM-101 A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC) NCT05851924Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: NALIRIFOX, AD-XRT and Capecitabine Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma NCT06141031Phase 12 sites📍 Aurora📍 St Louis Washington University School of Medicine · Tests: TTI-101, Stereotactic body radiation therapy Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma NCT05518903Phase 21 site📍 Rochester Mayo Clinic · Tests: Computed Tomography, Gallium Ga 68 FAPi-46, Positron Emission Tomography NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial NCT06821997Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Biospecimen Collection, Computed Tomography, Fluorouracil, Irinotecan Sucrosofate, Leucovorin Calcium
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy